Drawing for OSLER

USPTO serial 79254769

OSLER

Reviewed by CopyMark Law Group

Reg. 6039152Status 700Registered
Filing date
Status date
Registration date
Apr 28, 2020
Examiner
LEE, DOUGLAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OSLER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric Lamb

Eric Lamb Frost Brown Todd LLP111 Monument Circle, Suite 4500Indianapolis, IN 46204United States

Goods and services

ClassDescriptionStatusFirst use
001Assays and reagents for scientific or medical research purposesACTIVE—
005Pharmaceuticals for treating viruses, infections, infectious diseases, and skin disorders; medical preparations for treating viruses, infections, infectious diseases, and skin disorders; chemical preparations and reagents for medical purposes for treating viruses, infections, infectious diseases, and skin disorders; diagnostic preparations, substances, agents, reagents, assays and materials for medical purposes; diagnostic testing preparations, substances, agents, reagents, assays and materials for medical purposes, namely, for testing blood and body fluidsACTIVE—
009Scientific apparatus and instruments, namely, hand-held devices for withdrawing and testing blood for clinical, research, and scientific purposes and parts and fittings therefor; material testing apparatus and instruments, namely, electronic apparatus for identifying and testing pathogens and biomarkers in blood for clinical, research, and scientific purposes; monitoring, measuring, signaling and control apparatus and instruments, namely, apparatus and instruments for testing blood against a panel of biomarkers for clinical, research, and scientific purposes; audiovisual receivers; computer apparatus and instruments, namely, computer hardware and computer peripheral apparatus; recorded computer software for analyzing data obtained from blood samples; downloadable computer software for analyzing data obtained from blood samples; recorded application software for analyzing data obtained from blood samples; computer hardware for data capture, collection, recording, processing, transmission, reproduction, storage and communications; electrical and electronic components for computers; parts and fittings for all the aforementioned goodsACTIVE—
010Medical apparatus and instruments for use in obtaining blood samples; medical apparatus and instruments for testing blood for diagnostic use; medical apparatus and instruments for identifying pathogens and biomarkers from blood samples; diagnostic testing apparatus and instruments for the measurement of clinical biomarkers; parts and fittings for all the aforementioned goodsACTIVE—
025Clothing namely shirts, pants, coats, dresses and jackets; footwear; headgear namely hats, caps as clothing, and headwearACTIVE—
041Research in the field of education; consultancy, advisory and/or information services relating to or connected with the aforementioned servicesACTIVE—
042Product research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; new product design services; research, design and development of medical apparatus and instruments; research, design and development of medical diagnostic apparatus and instruments; research, design and development of diagnostic tests for the measurement of clinical biomarkers; software research, design and development services; consultancy, advisory and/or information services relating to or connected with the aforementioned servicesACTIVE—
044Medical services; medical testing for diagnostic purposes; medical testing, screening and analysis services relating to the diagnosis and/or treatment of disease; consultancy, advisory and/or information services relating to or connected with the aforementioned servicesACTIVE—
045Intellectual property licensing services; licensing of technology; licensing of manufacturing technology and/or manufacturing processes; licensing of intellectual property and/or intellectual property rights; licensing of industrial property and/or industrial property rights; licensing of patents and intellectual property in the field of confidential information, technical information and/or know-how; consultancy, advisory and/or information services relating to or connected with the aforementioned servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 28, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 8, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 8, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 2, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 28, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 28, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 28, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 28, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 28, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 26, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 6, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 29, 2020FIMPFINAL DISPOSITION PROCESSED—
Jul 28, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 28, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 11, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 11, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 7, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jan 22, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 22, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 3, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 26, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Dec 26, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 26, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 26, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 20, 2019ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 20, 2019PBSRWITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST—
Dec 11, 2019ALIEASSIGNED TO LIE—
Dec 9, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 25, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Nov 25, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 25, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 25, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 11, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 11, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 11, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 26, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 5, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 1, 2019RFNPREFUSAL PROCESSED BY IB—
May 11, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 11, 2019RFRRREFUSAL PROCESSED BY MPU—
Apr 18, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 17, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2019DOCKASSIGNED TO EXAMINER—
Mar 30, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 21, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance